Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Similar Stories
Related coverage based on topic and tags
Replimune's drug for advanced skin cancer fails to win FDA nod again - Reuters
Replimune's drug for advanced skin cancer fails to win FDA nod again Reuters
April 10, 2026 at 10:20 PMNew light shed on who benefits most from weight-loss jabs
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.
April 8, 2026 at 03:07 PM'Month of worry' over doctor strike surgery delay
The strike further delays Tom Lawson's gastric bypass surgery after a more than three-year wait.
April 8, 2026 at 12:32 PMChatGPT 'uncovered woman's rare condition' after years of misdiagnosis
Phoebe was told she'd be treated as a mental health patient if she kept returning to A&E.
April 10, 2026 at 05:11 AMOpenAI pauses UK data centre deal over energy costs and regulation
The project was part of a package of tech investment promising the UK could become an AI superpower.
April 9, 2026 at 08:36 PMHospital at centre of child HIV outbreak caught reusing syringes in undercover filming
Footage shows staff injecting without gloves and reusing syringes, but the hospital boss refuses to acknowledge it is genuine.
April 13, 2026 at 11:27 PM